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Himatanthus drasticus, also known as janaguba, is used popularly in Brazil’s Northeastern region in the 
treatment of cancer. However, no scientific reports are available. The present study is the first investigation 
on the antitumor activity of crude methanolic extract from Himatanthus drasticus leaves against 
Sarcoma 180 tumor and on its side effects including acute oral toxicity. The OECD 423 methodology 
was used to study acute oral toxicity, and the STOCK methodology to assess antitumor activity. The 
crude extract showed low toxicity at the tested doses (50, 300 and 2000 mg/kg) administered orally. 
The histopathological analyses demonstrated alterations in liver lung, spleen and kidney. It also showed 
activity against Sarcoma 180 tumor in male Swiss albino mice, evidencing tumor growth inhibition of 
67.7% and 68% at 300 mg/kg and 400 mg/kg doses, respectively.
Uniterms: Himatanthus drasticus/antitumor activity. Himatanthus drasticus/acute oral toxicity. Janaguba/
antitumor activity. Sarcoma 180/experimental study.
Himatanthus drasticus, conhecida popularmente como janaguba, tem uma longa história de emprego na 
cura do câncer no nordeste brasileiro, porém quase sem registro na literatura. O objetivo desse trabalho 
foi investigar a atividade antitumoral do extrato bruto metanólico das folhas de Himatanthus drasticus 
frente ao modelo experimental Sarcoma 180 e avaliar sua toxicidade aguda. A determinação da toxicidade 
aguda foi realizada segundo a metodologia da OECD 423 e o transplante do tumor sólido de sarcoma 
180 foi realizado seguindo a metodologia de Stock. O extrato apresentou baixa toxicidade nas doses 
testadas (50, 300 e 2000 mg/kg) por via oral. A análise histopatológica apresentou alterações em nível 
hepático, pulmonar, baço e renal. A atividade antineoplásica apresentou inibição tumoral significativa em 
relação ao grupo controle nas doses de 300 mg/kg e 400 mg/kg de peso do animal com um percentual 
de inibição de 67.7% e 68% respectivamente. Na menor dose analisada, 200 mg/kg, o percentual de 
inibição tumoral foi apenas de 32.8%.
Unitermos: Himatanthus drasticus/atividade antitumoral. Himatanthus drasticus/toxicidade aguda. 
Janaguba/atividade antitumoral. Sarcoma 180/estudo experimental.
INTRODUCTION
Plants contain a wide variety of compounds that 
have important biological activity including anticancer 
activity (Ramakrishna et al., 1984). Several drugs used 
to treat cancer are derived from natural products, such as 
Paclitaxel, a diterpenoid from Taxus brevifolia (Souza, 
2004), Vinca alkaloids such as vincristine and vinblastine 
from Catharanthus roseus (Almeida et al., 2005), natural 
alkaloid camptothecin from Camptotheca acuminata (Sil-
va et al., 2003), amongst others. Therefore, the analysis 
of plants is key to developing purified and well-defined 
chemical compounds for dose-controlled medications.
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The toxicity determination of plant extracts is rele-
vant because there is no single beneficial effect whereas 
biotransformation occurs, and these products can have 
toxic side effects which are harmful to human health (Hi-
lary et al., 2004).
The plant of the Himatanthus (Apocynaceae) genus 
is a medium-sized tree, growing on firm ground in South 
America from Southeastern regions of Brazil to the French 
Guiana (Plumel, 1991). In the Araripe National Forest, 
south of the State of Ceará, the species found is H. drasti-
cus, known as Janaguba. Its wood stem latex is popularly 
used in the treatment of cancer in Brazil’s Northeastern 
Region (Amaro et al., 2006a).
To our knowledge, only three papers have been repor-
ted in the literature on H. drasticus. However, there are no 
studies describing its leaves or anti-tumoral activity (Amaro 
et al., 2006a; Colares et al., 2008).
In 2008, Colares et al. isolated and identified an 
ethanolic extract from H. drasticus stem bark, namely, 
triterpene lupeol cinnamate which is probably a subs-
tance with potential for anti-tumor activity. The active 
ingredient of H. sucuuba was also isolated (an iridoid 
fulvoplumierin) and this also showed activity against the 
human epidermoid carcinoma of the nasopharynx (Perdue, 
Blomster, 1978).
In this study, the acute oral toxicity and antitumor 
activity against Sarcoma 180 tumor of the crude metha-
nolic extract from Himatanthus drasticus leaves was 
described.
EXPERIMENTAL
Plant material
Leaves of Himatanthus drasticus were collected 
in December of 2007 at Araripe National Forest, Jardim, 
Ceará, Brazil, and identified by Marlene Barbosa, PhD. 
A sample specimen (n° 48.961) was deposited at the 
herbarium Geraldo Mariz of the Federal University of 
Pernambuco (UFPE).
Extract preparation
The leaves were dried at room temperature in fresh 
air for seven days, and then cut into small fragments. 
The sample material (500g) was macerated with metha-
nol at room temperature (30 ± 2 ºC). Three extractions 
were made allowing 48h for each macerated extraction. 
Solvent was evaporated at 60 °C under reduced pressure 
and dried in a high vacuum for 10 h affording the crude 
extract (100.6 g).
Animals
60 day-old male Swiss albino mice weighing betwe-
en 25 and 35 g were housed under controlled temperature 
conditions (22 ± 2 ºC) and 12h light/dark cycles. Food and 
water were available ad libitum before and throughout the 
experiments. All studies were approved by the Research 
Ethics Committee (CEEA) of the Federal University of 
Pernambuco (n° 23076.03566/2008-71) in accordance with 
the National Institute of Health “Guide for the Care and Use 
of Laboratory Animals” (NIH publication no. 86-23, 1985).
Acute oral toxicity
The acute toxicity of the methanolic extract from the 
leaves of Himatanthus drasticus was evaluated in mice 
using the up-and-down procedure (OECD, 423). Male 
mice, (weighing from 25-35 g, aged from 6-8 weeks) re-
ceived a single initial gavage containing a 50 mg/kg dose 
of Himatanthus drasticus leaf methanolic extract. Three 
animals were used for each step. The dose level used as the 
starting dose was selected from one of the four fixed levels: 
50, 300 and 2000 mg per kg of body weight. The animals 
were continuously observed for toxicity development 
during the first 4 hours of administration of each dose. 
Finally, the number of survivors was noted after 24 hours, 
and these animals were then kept alive for a further 14 
days while observations were made on a daily basis. The 
experiment was then repeated after the end of the first trial.
Histopathological studies
Macroscopic analysis and histopathological examina-
tion of the bodies of those animals subjected to acute toxici-
ty at higher doses were performed. The liver, kidneys, spleen 
and lung tissues were excised and rinsed with an ice-cold 
normal saline solution in order to remove blood and debris 
adhering to the tissues. These tissues were then fixed in a 
10% formalin solution for 24 h. The fixative was removed 
by washing specimens thoroughly with running tap water 
overnight. After dehydration through a graded series of 
alcohols, the tissues were cleaned in methyl-benzoate, and 
embedded in paraffin wax. Sections were cut 7 μm-thick 
and stained with hematoxylin and eosin (Michelany, 1980). 
After dehydration and cleaning, the slides were mounted 
and observed under light microscope for details.
Antitumor activity
The transplant of the solid tumor of Sarcoma 180 
was carried out according to the methodology of Stock 
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et al. (1955). The treatment was initiated 48 hours post-
tumor transplant. The animals were divided into groups 
(n = 5): standard group (Cyclophosphamide, CTX, 10 
mg/kg), control group (NaCl 0.9%) and treated groups 
I, II and III, which received the methanolic extract from 
janaguba, at 200, 300 and 400 mg/kg doses, respectively. 
All substances had been managed by oral administration 
during the previous seven days. On the eighth day, the 
animals were sacrificed and their tumors removed and 
weighed. Subsequently, the difference between the treated 
groups and control group was calculated to give the index 
of tumor inhibition in accordance with the formula below.
TWI% = C - T x 100/C
Where:
TWI% = Tumor weight inhibition (%)
C = Mean tumor weight in control group animals
T = Mean tumor weight in treated group animals
Statistical analysis
The results are presented as mean ± S.E.M. and 
statistical significance between the groups was analyzed 
by mean of variance analysis followed by Student’s t test. 
P values < 0.05 were considered significant.
RESULTS AND DISCUSSION
Acute oral toxicity
In the study for acute toxicity, the animals were 
treated with a single dose of the extract in question for a 
period of approximately 24 h (Simões, 2003). The oral 
administration of the methanolic extract from H. drasticus 
leaves at doses of 50 and 300 mg presented no alteration in 
the animals during the first 30 minutes of observation. The 
animals remained without changes after 14 days. Within 
the first 15 minutes of 2000 mg/kg dose administration, 
the animals presented excitability and agitation including 
exophthalmia, agitation, vibrissa, stereotyped and circle 
movements. They also presented increased respiratory 
rate, position in claw, snout edema, lack of flee attempt. 
After this period, depressive reactions such as lowering of 
the posterior train and prostration became evident. After 14 
days, no mortality or changes in behavior were observed. 
The excitability followed by depressive behaviors suggests 
a reduction in the amount of stimulant neurotransmitters 
during the excitation phase (Fai et al., 2005). During the 
observation period, animals displayed no variation in their 
general appearance. These results obtained for methanolic 
extract from H. drasticus leaves were in accordance with 
the norms established for OECD 423, and presented low 
toxicity for oral administration at 2000 mg/kg. The general 
results for acute oral toxicity are shown in Table I.
Histopathological studies
Animal bodies were macroscopically preserved. 
Histopathological examination of the livers presented 
hepatic congestion at sinusoids and the portal vessel, pe-
ricentre globular micro-steatosis, Kuffe cell proliferation, 
hepatocyte diffuse necrosis and mononuclear infiltrate. In 
the kidneys, the findings were glomerular atrophy, capsule 
thickening, renal cortico-medullary congestion, hemor-
rhage and mononuclear infiltrate. The pulmonary findings 
were alveolar interstitial thickening, intense pulmonary 
congestion, mononuclear infiltrate, pneumocyte-type II 
proliferation, pulmonary emphysema, edema and vessel 
thickening. In the spleen, the authors noted red pulp con-
gestion, white pulp hyperplasia and apoptotic cells at the 
germinal center.
Antitumor activity
Laboratory animals represent a valuable experi-
mental system for the understanding of the mechanism of 
cancer in humans. The majority of the currently accepted 
concepts of tumorigenesis are strongly influenced by 
cancer development models in mice. Mice organisms are 
accessible models and possess similar systems to humans 
(Kamb, 2005). Sarcoma 180 is an original mouse tumor 
and one of the most frequently used cell lineages in the 
research of antitumor activity (Lee et al., 2003; Magalhães 
et al., 2006).
The antitumor activity of the methanolic extract 
from H. drasticus leaves was tested by oral administration 
against the Sarcoma 180 experimental model. Figure 1 
shows the mean weight of the tumors in the control group 
(NaCl 0.9% Solution), standard group (cyclophosphamide, 
CTX, 10mg/kg), treated I (200 mg/kg), treated II (300 mg/kg) 
and treated III (400 mg/kg) groups. The standard group 
presented significant tumor growth inhibition of 70.4% 
in comparison to the control group. The treated groups 
also presented a reduction in tumor growth in relation 
to the control group; however, the doses of 300 mg/kg 
and 400 mg/kg also demonstrated marked tumor growth 
inhibition activity of 67.7% and 68%, respectively. At 
the 200 mg/kg dose, tumor growth inhibition was 32.8%.
The macroscopic analysis of the animals of the 
control group revealed hemorrhagic ascites; solid and in-
vasive tumor, adhered to epidermis and well vascularized. 
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However, in the treated groups, only the Treated I group 
(200 mg/kg) presented ascites, solid and invasive tumor, 
adhered to epidermis and well vascularized. The Treated II 
(300 mg/kg) and Treated III (400 mg/kg) groups presented 
well described solid tumors which were less vascularized 
than control group tumors.
The mechanism underlying janaguba antitumor 
activity has not yet been elucidated. It is known that the 
Himatanthus genus has iridoid and triterpene in its chemi-
cal constitution, and one of these substances is likely res-
ponsible for the activity. Detailed studies are being carried 
TABLE I – Toxic effects for methanolic extract from H. drasticus 
leaves in male Swiss albino mice (Mus musculus)
EFFECTS DOSES (mg/kg)
STIMULANT 50 300 2000
Tachycardia - - -
Tachypnea - - +
Piloerection - - + +
Agitation - - +
Exophthalmia - - +
Stereotyped Movements - - + + +
Circle Movements - - + +
Vibrissa Movements - - +
Tail Curl - - +
Fine/Coarse Tremors - - -
Position in Claw - - +
Flee Reaction - - + + +
DEPRESSIVE
Lowering of the posterior member - - +
Apnea - - -
Alteration in gait - - -
Sleepiness - - -
Prostration - - + +
OTHERS
Fecal Elimination - - +
Diuresis - - +
Abdominal Movements - - -
Petechiae - - +
Snout Edema - - + +
Cyanosis - - -
Photophobia - - -
Reflux - - -
Data obtained within first 30 minutes of oral administration.
(-) No Effect; (+) Mild Effect; (++) Moderate Effect; (+++) 
Severe Effect.
FIGURE 1 – Mean tumor weight. *p < 0.05 comparing treated 
groups with control group ( normal saline solution). Student’s 
t test (n = 5/group).
to clarify the antitumor activity of leaves of H. drasticus 
as well as to determine new routes of drug administration.
Based on these results, we can conclude that the 
methanolic extract from H. drasticus leaves possesses low 
toxicity and significant antitumor activity at the tested do-
ses administered orally. The results for antitumor activity 
were very good in relation to control cyclophosphamide, 
the synthetic drug widely used in chemotherapy protocols. 
The extract was also found to be safe in terms of acute 
toxicity in experimental animal models whereas further 
studies are necessary on its chronic toxicity, mutagenicity 
and carcinogenicity to ascertain the safety and benefits of 
the plant.
ACKNOWLEDGEMENTS
The authors would like to thank the Conselho 
Nacional de Desenvolvimento Científico e Tecnológico 
(CNPq-Brazil) for financial support and scholarships. 
Authors also extend their thanks to Dr. Marlene Barbosa 
for botanical identification.
REFERENCES
ALMEIDA,  V.  L . ;  LEITÃO,  A. ;  REINA,  L.  C.  B. ; 
MONTANARI, C. A.; DONNICI, C. L.; LOPES, M. T. P. 
Câncer e agentes antineoplásicos ciclo-celular específicos 
e ciclo-celular não específicos que interagem com o DNA: 
uma introdução. Quim. Nova, v.28, n.1, p.118-129, 2005.
AMARO, M. S.; FILHO, S. M.; GUIMARÃES, R. M.; 
TEÓFILO, E. M. Influência da temperatura e regime de 
luz na germinação de sementes de Janaguba (Himatanthus 
drasticus) (MART.) Plumel.-Apocynaceae. Ciênc. Agrotec. 
Lavras, v.30, n.3, p.450-457, 2006a.
Antitumor activity of leaves of Himatanthus drasticus (Mart.) Plumel-Apocynaceae (Janaguba) in the treatment of Sarcoma 180 tumor 203
AMARO, M. S.; FILHO, S. M.; GUIMARÃES, R. M; 
TEÓFILO, E. M. Morfologia de frutos, sementes e de 
plântulas de Janaguba Himatanthus drasticus (MART.) 
Plumel.-Apocynaceae. Rev. Bras. Sementes, v.28, n.1, 
p.63-71, 2006b.
COLARES, A. V.; CORDEIRO, L. N.; COSTA, J. G. M.; 
SILVEIRA, E. R.; CAMPOS, A. R.; CARDOSO, A. 
H. Phytochemical and biological preliminary study 
of Himatanthus drasticus (Mart.) Plumel (Janaguba). 
Pharmacog. Mag., v.4, n.14, p.73-77, 2008.
FAI, P. B. A.; FAGANDE, S. O. Acute toxicity of Euphorbia 
Kamerunia on Oreochrmis niloticus. Ecotoxicol. Environ. 
Saf., v.62, n.1, p.123-131, 2005.
HILARY, J. E.; ISRAILI, Z. H.; LYOUSSI, B. Acute and chronic 
toxicological studies of Ajuga ivain experimental animals. 
J. Ethnopharmacol., v.91, n.1, p.43-50, 2004.
LEE, Y. L.; KIM, H. J.; LEE, M. S.; KIM, J. M.; HAN, 
J. S.; HONG, E. K.; KWON, M. S.; LEE, M. J. Oral 
administration of Agaricus blazei (H1 strain) inhibited 
tumor growth in a sarcoma 180 inoculation model. Exp. 
Anim., v.52, n.5, p.371-375, 2003.
KAMB, A. What’s wrong with our cancer models? Nature Rev. 
Drug Discov., v.4, n.2, p.161-165, 2005.
MAGALHÃES, H. I. F.; VERAS, M. L.; TORRES, M. R.; 
ALVES, A. P. N. N.; PESSOA, O. D. L.; SILVEIRA, E. R.; 
COSTA-LOTUFO, L. V.; MORAES, M. O.; PESSOA, C. 
In vitro and in vivo antitumor activity of physalins B and D 
from Physalis angulata. J. Pharm. Pharmacol., v.58, n.2, 
p.235-241, 2006.
MICHALANY, J. Técnica histológica em anatomia patológica. 
São Paulo: Editora Pedagógica e Universitária Ltda, 1980. 
p.277.
ORGANIZATION FOR ECONOMIC COOPERATION 
AND DEVELOPMENT. OECD. Guideline for Testing 
of Chemicals. Guideline 423. Acute Oral Toxicity-Acute 
Class Method. Adopted 17th December 2001. Available at: 
<http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/
OECD_GL423.pdf>.Accessed on: 10 dec. 2007. 
PERDUE, G. P.; BLOMSTER, R. N. South American plants III: 
Isolation of fulvoplumierin from Himatanthus sucuuba (M. 
Arg.) Woodson (Apocynaceae). J. Pharm. Sci., v.67, n.9, 
p.1322-1323, 1978.
PLUMEL, M. M. Le genre Himatanthus(Apocinaceae). 
Revisión taxonomique: brandea. Bol. Herb. Bradeanu, v.5, 
p.1-20, 1991.
RAMAKRISHNA, Y.; MAHONOR, A. I.; MAMATA, P.; 
SHREEKANT, K. G. Plants and novel antitumour agents: 
A review. Indian Drugs, v.21, n.1, p.173-185, 1984.
SILVA, M. N.; FERREIRA, V. F.; SOUZA, M. C. B. Um 
panorama atual da química e da farmacologia de 
naftoquinonas, com ênfase na β-lapachona e derivados. 
Quim. Nova, v.26, n.3, p.407-416, 2003.
SIMÕES, C. M. O. Farmacognosia: da planta ao medicamento. 
5.ed. Porto Alegre: UFRGS/UFCS, 2004. p.256.
SOUZA, M. V. N. Novos produtos naturais capazes de atuar 
na estabilização de microtúbulos, um importante alvo no 
combate ao câncer. Quim. Nova, v.27, n.2, p.308-312, 2004.
STOCK, C. C.; CLARCK, D. A.; PHILIPS, F. S. Sarcoma 180 – 
inhibitor screening date. Cancer Res., v.15, n.2, p.2-3, 1955.
Received for publication on 22nd January 2009
Accepted for publication on 29th November 2009
